Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancerJerusalem, Guy ; ; et alin Breast Cancer Research and Treatment (2011), 125(2), 447-455 Detailed reference viewed: 53 (12 ULg) |
||